CIBC Asset Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GF
FLAM
CIBC Asset Management's NEO Position: Q4 2023 in Review
CIBC Asset Management sold out of NeoGenomics (NEO) in Q4 2023, closing a stake of 12,851 shares — an estimated $158K sold.
CIBC Asset Management first reported a position in NEO in Q4 2020 and held it in 7 quarters. The position peaked at $333K in Q4 2021. 287 funds tracked by Wall St. Rank hold NEO as of Q4 2023.
- CIBC Asset Management reported no remaining NeoGenomics position as of Q4 2023 after selling out during the quarter.
- CIBC Asset Management sold 12,851 NeoGenomics shares in Q4 2023, an estimated $158K.
- CIBC Asset Management first reported a position in NeoGenomics in Q4 2020 and held it in 7 quarters.
- CIBC Asset Management's NeoGenomics position peaked at $333K in Q4 2021.
- 287 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2023.
Based on CIBC Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.